Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

NCT00005018 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Hydroxyurea
DRUG: Abacavir sulfate
DRUG: Efavirenz
DRUG: Didanosine

Sponsor

Glaxo Wellcome